JOHNSON & JOHNSON — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Hait William | See Remarks | Option Exercise | 1,285 | — | — | 42,316 | Feb 12, 2024 |
| Forminard Elizabeth | Executive VP, General Counsel | Tax Withholding | 1,034 | $157.40 | $162,752 | 7,925 | Feb 12, 2024 |
| Fasolo Peter | Exec VP, Chief HR Officer | Option Exercise | 2,152 | — | — | 118,644 | Feb 12, 2024 |
| Duato Joaquin | CEO and Chairman of the Board | Option Exercise | 31,351 | — | — | 371,972 | Feb 12, 2024 |
| Decker Robert J | VP Corporate Controller | Tax Withholding | 523 | $157.40 | $82,320 | 18,746 | Feb 12, 2024 |
| Wengel Kathryn E | EVP, Chief TO and Risk Officer | Option Exercise | 11,826 | — | — | 87,027 | Feb 12, 2024 |
| Wengel Kathryn E | EVP, Chief TO and Risk Officer | Tax Withholding | 27,333 | $156.76 | $4,284,721 | 75,201 | Feb 9, 2024 |
| Duato Joaquin | CEO and Chairman of the Board | Tax Withholding | 98,662 | $156.76 | $15,466,255 | 340,621 | Feb 9, 2024 |
| Taubert Jennifer L | EVP, WW Chair, Pharmaceuticals | Sale | 59,397 | $156.27 | $9,281,969 | 141,416 | Feb 8, 2024 |
| Wengel Kathryn E | EVP, Chief TO and Risk Officer | Tax Withholding | 1,009 | $156.33 | $157,737 | 66,896 | Feb 8, 2024 |
| Wolk Joseph J | Exec VP, CFO | Tax Withholding | 1,047 | $156.33 | $163,678 | 52,864 | Feb 8, 2024 |
| Swanson James D. | See Remarks | Tax Withholding | 554 | $156.33 | $86,607 | 10,557 | Feb 8, 2024 |
| Duato Joaquin | CEO and Chairman of the Board | Tax Withholding | 2,269 | $156.33 | $354,713 | 308,314 | Feb 8, 2024 |
| Forminard Elizabeth | Executive VP, General Counsel | Option Exercise | 979 | — | — | 6,463 | Feb 8, 2024 |
| Schmid Timothy | EVP, WW Chair, MedTech | Tax Withholding | 1,001 | $156.33 | $156,486 | 9,942 | Feb 8, 2024 |
| Fasolo Peter | Exec VP, Chief HR Officer | Option Exercise | 2,135 | — | — | 104,465 | Feb 8, 2024 |
| Hait William | See Remarks | Tax Withholding | 1,113 | $156.33 | $173,995 | 33,384 | Feb 8, 2024 |
| Broadhurst Vanessa | EVP, Global Corp Affairs | Tax Withholding | 703 | $156.33 | $109,900 | 20,380 | Feb 8, 2024 |
| Decker Robert J | VP Corporate Controller | Tax Withholding | 215 | $156.33 | $33,611 | 17,357 | Feb 8, 2024 |
| Fasolo Peter | Exec VP, Chief HR Officer | Disposition | 232 | — | — | 102,464 | Aug 23, 2023 |
| Duato Joaquin | CEO and Chairman of the Board | Disposition | 11,035 | — | — | 305,358 | Aug 23, 2023 |
| Hait William | See Remarks | Disposition | 696 | — | — | 87,051 | Aug 23, 2023 |
| McEvoy Ashley | EVP, WW Chair, MedTech | Disposition | 2,787 | — | — | 52,038 | Aug 23, 2023 |
| Wolk Joseph J | Exec VP, CFO | Disposition | 67 | — | — | 50,275 | Aug 23, 2023 |
| Hait William | See Remarks | Sale | 14,698 | $172.00 | $2,528,056 | 87,747 | Jul 26, 2023 |
| Fasolo Peter | Exec VP, Chief HR Officer | Sale | 20,000 | $170.32 | $3,406,400 | 102,696 | Jul 25, 2023 |
| Wengel Kathryn E | EVP, Chief TO and Risk Officer | Sale | 12,465 | $160.00 | $1,994,400 | 65,934 | Jun 12, 2023 |
| Wolk Joseph J | Exec VP, CFO | Gift | 55 | — | — | 50,342 | May 24, 2023 |
| Swanson James D. | See Remarks | Sale | 1,062 | $154.66 | $164,199 | 9,215 | Mar 6, 2023 |
| Wolk Joseph J | Exec VP, CFO | Award / Grant | 20,693 | — | — | 58,975 | Feb 13, 2023 |
| Wengel Kathryn E | EVP, Chief TO and Risk Officer | Award / Grant | 10,839 | — | — | 83,290 | Feb 13, 2023 |
| Taubert Jennifer L | EVP, WW Chair, Pharmaceuticals | Tax Withholding | 10,569 | $162.01 | $1,712,284 | 139,590 | Feb 13, 2023 |
| Swanson James D. | See Remarks | Tax Withholding | 918 | $162.01 | $148,725 | 10,277 | Feb 13, 2023 |
| Mongon Thibaut | Exec VP, WW Chair, Cons Health | Tax Withholding | 6,430 | $162.01 | $1,041,724 | 65,915 | Feb 13, 2023 |
| McEvoy Ashley | EVP, WW Chair, MedTech | Tax Withholding | 7,158 | $162.01 | $1,159,668 | 54,825 | Feb 13, 2023 |
| Hait William | See Remarks | Award / Grant | 9,640 | — | — | 92,333 | Feb 13, 2023 |
| Fasolo Peter | Exec VP, Chief HR Officer | Tax Withholding | 5,765 | $162.01 | $933,988 | 122,696 | Feb 13, 2023 |
| Duato Joaquin | CEO and Chairman of the Board | Tax Withholding | 13,599 | $162.01 | $2,203,174 | 316,393 | Feb 13, 2023 |
| Decker Robert J | VP Corporate Controller | Tax Withholding | 397 | $162.01 | $64,318 | 16,917 | Feb 13, 2023 |
| Forminard Elizabeth | Executive VP, General Counsel | Tax Withholding | 924 | $162.01 | $149,697 | 5,484 | Feb 13, 2023 |
| Broadhurst Vanessa | EVP, Global Corp Affairs | Tax Withholding | 1,440 | $162.01 | $233,294 | 19,203 | Feb 13, 2023 |
| Duato Joaquin | CEO and Chairman of the Board | Option Exercise | 5,220 | — | — | 300,940 | Feb 10, 2023 |
| Wengel Kathryn E | EVP, Chief TO and Risk Officer | Option Exercise | 1,807 | — | — | 73,118 | Feb 10, 2023 |
| Wolk Joseph J | Exec VP, CFO | Tax Withholding | 979 | $162.08 | $158,676 | 38,282 | Feb 10, 2023 |
| Taubert Jennifer L | EVP, WW Chair, Pharmaceuticals | Option Exercise | 3,570 | — | — | 130,026 | Feb 10, 2023 |
| McEvoy Ashley | EVP, WW Chair, MedTech | Option Exercise | 2,999 | — | — | 44,812 | Feb 10, 2023 |
| Hait William | See Remarks | Option Exercise | 3,856 | — | — | 84,092 | Feb 10, 2023 |
| Mongon Thibaut | Exec VP, WW Chair, Cons Health | Tax Withholding | 826 | $162.08 | $133,878 | 58,635 | Feb 10, 2023 |
| Forminard Elizabeth | Executive VP, General Counsel | Tax Withholding | 380 | $162.08 | $61,590 | 3,853 | Feb 10, 2023 |
| Decker Robert J | VP Corporate Controller | Option Exercise | 581 | — | — | 16,054 | Feb 10, 2023 |